Health Canada inspection
Novartis Pharmaceuticals Canada Inc: Health Canada inspection of Oct 25, 2021
Health Canada · GVP · rating C
Key facts
| Establishment | Novartis Pharmaceuticals Canada Inc |
|---|---|
| City | Mississauga |
| Province | Ontario |
| Country | Canada |
| Program | GVP |
| Start date | Oct 12, 2021 |
| End date | Oct 25, 2021 |
| Rating | C |
| Rating description | Compliant |
| Licence number | 100273 |
At a glance
- 10–99 Observations cited
- 1–9 Inspections of this establishment
- Yes Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.
Source: Health Canada, Drug and Health Product Inspections. Contains information licensed under the Open Government Licence – Canada · Source date: